The Tyrosine Phosphatase Shp2 in Development and Cancer

Advances in Cancer Research

Volumn 106, Issue , 2010, Pages 53-89

  Grossmann, Katja S ^a   Rosário, Marta ^a   Birchmeier, Carmen ^a   Birchmeier, Walter ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE SHP 2;

ANIMAL; ENZYMOLOGY; HUMAN; MORPHOGENESIS; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; MORPHOGENESIS; NEOPLASMS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; SIGNAL TRANSDUCTION;

EID: 77954638588     PISSN: 0065230X     EISSN: 21625557     Source Type: Book Series    
DOI: 10.1016/S0065-230X(10)06002-1     Document Type: Chapter

References (185)

1. Adachi, M., Sekiya, M., Miyachi, T., Matsuno, K., Hinoda, Y., Imai, K., Yachi, A., Molecular cloning of a novel protein-tyrosine phosphatase SH-PTP3 with sequence similarity to the src-homology region 2. FEBS Lett. 314 (1992), 335–339.
2. Ahmad, S., Banville, D., Zhao, Z., Fischer, E.H., Shen, S.H., A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains. Proc. Natl. Acad. Sci. USA 90 (1993), 2197–2201.
3. Alberola-Ila, J., Forbush, K.A., Seger, R., Krebs, E.G., Perlmutter, R.M., Selective requirement for MAP kinase activation in thymocyte differentiation. Nature 373 (1995), 620–623.
4. Ali, S., Chen, Z., Lebrun, J.J., Vogel, W., Kharitonenkov, A., Kelly, P.A., Ullrich, A., PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation. EMBO J. 15 (1996), 135–142.
5. Ali, S., Nouhi, Z., Chughtai, N., Ali, S., SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor. J. Biol. Chem. 278 (2003), 52021–52031.
6. Allard, J.D., Chang, H.C., Herbst, R., McNeill, H., Simon, M.A., The SH2-containing tyrosine phosphatase corkscrew is required during signaling by sevenless, Ras1 and Raf. Development 122 (1996), 1137–1146.
7. Altman, A.J., Palmer, C.G., Baehner, R.L., Juvenile “chronic granulocytic” leukemia: a panmyelopathy with prominent monocytic involvement and circulating monocyte colony-forming cells. Blood 43 (1974), 341–350.
8. Araki, T., Nawa, H., Neel, B.G., Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors. J. Biol. Chem. 278 (2003), 41677–41684.
9. Araki, T., Mohi, M.G., Ismat, F.A., Bronson, R.T., Williams, I.R., Kutok, J.L., Yang, W., Pao, L.I., Gilliland, D.G., Epstein, J.A., Neel, B.G., Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat. Med. 10 (2004), 849–857.
10. Araki, T., Chan, G., Newbigging, S., Morikawa, L., Bronson, R.T., Neel, B.G., Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation. Proc. Natl. Acad. Sci. USA 106 (2009), 4736–4741.
11. Arman, E., Haffner-Krausz, R., Chen, Y., Heath, J.K., Lonai, P., Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl. Acad. Sci. USA 95 (1998), 5082–5087.
12. Arrandale, J.M., Gore-Willse, A., Rocks, S., Ren, J.M., Zhu, J., Davis, A., Livingston, J.N., Rabin, D.U., Insulin signaling in mice expressing reduced levels of Syp. J. Biol. Chem. 271 (1996), 21353–21358.
13. Bard-Chapeau, E.A., Hevener, A.L., Long, S., Zhang, E.E., Olefsky, J.M., Feng, G.S., Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action. Nat. Med. 11 (2005), 567–571.
14. Bard-Chapeau, E.A., Yuan, J., Droin, N., Long, S., Zhang, E.E., Nguyen, T.V., Feng, G.S., Concerted functions of Gab1 and Shp2 in liver regeneration and hepatoprotection. Mol. Cell. Biol. 26 (2006), 4664–4674.
15. Barford, D., Neel, B.G., Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2. Structure 6 (1998), 249–254.
16. Bates, S.H., Stearns, W.H., Dundon, T.A., Schubert, M., Tso, A.W., Wang, Y., Banks, A.S., Lavery, H.J., Haq, A.K., Maratos-Flier, E., Neel, B.G., Schwartz, M.W., et al. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421 (2003), 856–859.
17. Bentires-Alj, M., Paez, J.G., David, F.S., Keilhack, H., Halmos, B., Naoki, K., Maris, J.M., Richardson, A., Bardelli, A., Sugarbaker, D.J., Richards, W.G., Du, J., et al. Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 64 (2004), 8816–8820.
18. Berchtold, S., Volarevic, S., Moriggl, R., Mercep, M., Groner, B., Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription. Mol. Endocrinol. 12 (1998), 556–567.
19. Birchmeier, C., ErbB receptors and the development of the nervous system. Exp. Cell Res. 315 (2009), 611–618.
20. Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A., Frank, D.A., Rozovsky, I., Stahl, N., Yancopoulos, G.D., Greenberg, M.E., Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278 (1997), 477–483.
21. Borowiak, M., Garratt, A.N., Wustefeld, T., Strehle, M., Trautwein, C., Birchmeier, C., Met provides essential signals for liver regeneration. Proc. Natl. Acad. Sci. USA 101 (2004), 10608–10613.
22. Buckingham, M., Meilhac, S., Zaffran, S., Building the mammalian heart from two sources of myocardial cells. Nat. Rev. Genet. 6 (2005), 826–835.
23. Carta, C., Pantaleoni, F., Bocchinfuso, G., Stella, L., Vasta, I., Sarkozy, A., Digilio, C., Palleschi, A., Pizzuti, A., Grammatico, P., Zampino, G., Dallapiccola, B., et al. Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype. Am. J. Hum. Genet. 79 (2006), 129–135.
24. Chan, R.J., Leedy, M.B., Munugalavadla, V., Voorhorst, C.S., Li, Y., Yu, M., Kapur, R., Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor. Blood 105 (2005), 3737–3742.
25. Chan, G., Kalaitzidis, D., Neel, B.G., The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev. 27 (2008), 179–192.
26. Chan, G., Kalaitzidis, D., Usenko, T., Kutok, J.L., Yang, W., Mohi, M.G., Neel, B.G., Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis. Blood 113 (2009), 4414–4424.
27. Chapman, R.S., Lourenco, P.C., Tonner, E., Flint, D.J., Selbert, S., Takeda, K., Akira, S., Clarke, A.R., Watson, C.J., Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev. 13 (1999), 2604–2616.
28. Chen, Y., Wen, R., Yang, S., Schuman, J., Zhang, E.E., Yi, T., Feng, G.S., Wang, D., Identification of Shp-2 as a Stat5A phosphatase. J. Biol. Chem. 278 (2003), 16520–16527.
29. Choong, K., Freedman, M.H., Chitayat, D., Kelly, E.N., Taylor, G., Zipursky, A., Juvenile myelomonocytic leukemia and Noonan syndrome. J. Pediatr. Hematol. Oncol. 21 (1999), 523–527.
30. Christiansen, J.H., Coles, E.G., Wilkinson, D.G., Molecular control of neural crest formation, migration and differentiation. Curr. Opin. Cell Biol. 12 (2000), 719–724.
31. Chughtai, N., Schimchowitsch, S., Lebrun, J.J., Ali, S., Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells. J. Biol. Chem. 277 (2002), 31107–31114.
32. Cotton, J.L., Williams, R.G., Noonan syndrome and neuroblastoma. Arch. Pediatr. Adolesc. Med. 149 (1995), 1280–1281.
33. Crane, J.F., Trainor, P.A., Neural crest stem and progenitor cells. Annu. Rev. Cell Dev. Biol. 22 (2006), 267–286.
34. Cressman, D.E., Greenbaum, L.E., DeAngelis, R.A., Ciliberto, G., Furth, E.E., Poli, V., Taub, R., Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274 (1996), 1379–1383.
35. Crompton, T., Gilmour, K.C., Owen, M.J., The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte. Cell 86 (1996), 243–251.
36. Cross, J.C., Genetic insights into trophoblast differentiation and placental morphogenesis. Semin. Cell Dev. Biol. 11 (2000), 105–113.
37. Digilio, M.C., Pacileo, G., Sarkozy, A., Limongelli, G., Conti, E., Cerrato, F., Marino, B., Pizzuti, A., Calabro, R., Dallapiccola, B., Familial aggregation of genetically heterogeneous hypertrophic cardiomyopathy: a boy with LEOPARD syndrome due to PTPN11 mutation and his nonsyndromic father lacking PTPN11 mutations. Birth Defects Res. A Clin. Mol. Teratol. 70 (2004), 95–98.
38. Dong, Z., Brennan, A., Liu, N., Yarden, Y., Lefkowitz, G., Mirsky, R., Jessen, K.R., Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors. Neuron 15 (1995), 585–596.
39. Emanuel, P.D., Bates, L.J., Castleberry, R.P., Gualtieri, R.J., Zuckerman, K.S., Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 77 (1991), 925–929.
40. Emanuel, P.D., Shannon, K.M., Castleberry, R.P., Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy. Mol. Med. Today 2 (1996), 468–475.
41. Fausto, N., Campbell, J.S., The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech. Dev. 120 (2003), 117–130.
42. Fausto, N., Laird, A.D., Webber, E.M., Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J. 9 (1995), 1527–1536.
43. Feldman, B., Poueymirou, W., Papaioannou, V.E., DeChiara, T.M., Goldfarb, M., Requirement of FGF-4 for postimplantation mouse development. Science 267 (1995), 246–249.
44. Feng, G.S., Shp2-mediated molecular signaling in control of embryonic stem cell self-renewal and differentiation. Cell Res. 17 (2007), 37–41.
45. Feng, G.S., Hui, C.C., Pawson, T., SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science 259 (1993), 1607–1611.
46. Fornaro, M., Burch, P.M., Yang, W., Zhang, L., Hamilton, C.E., Kim, J.H., Neel, B.G., Bennett, A.M., SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth. J. Cell Biol. 175 (2006), 87–97.
47. Fragale, A., Tartaglia, M., Wu, J., Gelb, B.D., Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. Hum. Mutat. 23 (2004), 267–277.
48. Freeman, R.M. Jr., Plutzky, J., Neel, B.G., Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc. Natl. Acad. Sci. USA 89 (1992), 11239–11243.
49. Gao, Q., Wolfgang, M.J., Neschen, S., Morino, K., Horvath, T.L., Shulman, G.I., Fu, X.Y., Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc. Natl. Acad. Sci. USA 101 (2004), 4661–4666.
50. Garratt, A.N., Voiculescu, O., Topilko, P., Charnay, P., Birchmeier, C., A dual role of erbB2 in myelination and in expansion of the schwann cell precursor pool. J. Cell Biol. 148 (2000), 1035–1046.
51. Gauthier, A.S., Furstoss, O., Araki, T., Chan, R., Neel, B.G., Kaplan, D.R., Miller, F.D., Control of CNS cell-fate decisions by SHP-2 and its dysregulation in Noonan syndrome. Neuron 54 (2007), 245–262.
52. Goldin, S.N., Papaioannou, V.E., Paracrine action of FGF4 during periimplantation development maintains trophectoderm and primitive endoderm. Genesis 36 (2003), 40–47.
53. Gotoh, N., Manova, K., Tanaka, S., Murohashi, M., Hadari, Y., Lee, A., Hamada, Y., Hiroe, T., Ito, M., Kurihara, T., Nakazato, H., Shibuya, M., et al. The docking protein FRS2alpha is an essential component of multiple fibroblast growth factor responses during early mouse development. Mol. Cell. Biol. 25 (2005), 4105–4116.
54. Grossmann, K.S., Wende, H., Paul, F.E., Cheret, C., Garratt, A.N., Zurborg, S., Feinberg, K., Besser, D., Schulz, H., Peles, E., Selbach, M., Birchmeier, W., et al. The tyrosine phosphatase Shp2 (PTPN11) directs Neuregulin-1/ErbB signaling throughout Schwann cell development. Proc. Natl. Acad. Sci. USA 106 (2009), 16704–16709.
55. Gutch, M.J., Flint, A.J., Keller, J., Tonks, N.K., Hengartner, M.O., The Caenorhabditis elegans SH2 domain-containing protein tyrosine phosphatase PTP-2 participates in signal transduction during oogenesis and vulval development. Genes Dev. 12 (1998), 571–585.
56. Hadari, Y.R., Kouhara, H., Lax, I., Schlessinger, J., Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation. Mol. Cell. Biol. 18 (1998), 3966–3973.
57. Hagihara, K., Zhang, E.E., Ke, Y.H., Liu, G., Liu, J.J., Rao, Y., Feng, G.S., Shp2 acts downstream of SDF-1alpha/CXCR4 in guiding granule cell migration during cerebellar development. Dev. Biol 334 (2009), 276–284.
58. Hanna, N., Montagner, A., Lee, W.H., Miteva, M., Vidal, M., Vidaud, M., Parfait, B., Raynal, P., Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1. FEBS Lett. 580 (2006), 2477–2482.
59. Hennighausen, L., Robinson, G.W., Information networks in the mammary gland. Nat. Rev. Mol. Cell Biol. 6 (2005), 715–725.
60. Herbst, R., Carroll, P.M., Allard, J.D., Schilling, J., Raabe, T., Simon, M.A., Daughter of sevenless is a substrate of the phosphotyrosine phosphatase Corkscrew and functions during sevenless signaling. Cell 85 (1996), 899–909.
61. Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M.J., Shoelson, S.E., Crystal structure of the tyrosine phosphatase SHP-2. Cell 92 (1998), 441–450.
62. Holgado-Madruga, M., Emlet, D.R., Moscatello, D.K., Godwin, A.K., Wong, A.J., A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379 (1996), 560–564.
63. Horsley, V., Friday, B.B., Matteson, S., Kegley, K.M., Gephart, J., Pavlath, G.K., Regulation of the growth of multinucleated muscle cells by an NFATC2-dependent pathway. J. Cell Biol. 153 (2001), 329–338.
64. Huh, C.G., Factor, V.M., Sanchez, A., Uchida, K., Conner, E.A., Thorgeirsson, S.S., Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc. Natl. Acad. Sci. USA 101 (2004), 4477–4482.
65. Ijiri, R., Tanaka, Y., Keisuke, K., Masuno, M., Imaizumi, K., A case of Noonan's syndrome with possible associated neuroblastoma. Pediatr. Radiol. 30 (2000), 432–433.
66. Ivins Zito, C., Kontaridis, M.I., Fornaro, M., Feng, G.S., Bennett, A.M., SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis. J. Cell. Physiol. 199 (2004), 227–236.
67. Jessen, K.R., Mirsky, R., The origin and development of glial cells in peripheral nerves. Nat. Rev. Neurosci. 6 (2005), 671–682.
68. Jiang, X., Rowitch, D.H., Soriano, P., McMahon, A.P., Sucov, H.M., Fate of the mammalian cardiac neural crest. Development 127 (2000), 1607–1616.
69. Johe, K.K., Hazel, T.G., Muller, T., Dugich-Djordjevic, M.M., McKay, R.D., Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev. 10 (1996), 3129–3140.
70. Ke, Y., Lesperance, J., Zhang, E.E., Bard-Chapeau, E.A., Oshima, R.G., Muller, W.J., Feng, G.S., Conditional deletion of Shp2 in the mammary gland leads to impaired lobulo-alveolar outgrowth and attenuated Stat5 activation. J. Biol. Chem. 281 (2006), 34374–34380.
71. Ke, Y., Zhang, E.E., Hagihara, K., Wu, D., Pang, Y., Klein, R., Curran, T., Ranscht, B., Feng, G.S., Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality. Mol. Cell. Biol. 27 (2007), 6706–6717.
72. Kegley, K.M., Gephart, J., Warren, G.L., Pavlath, G.K., Altered primary myogenesis in NFATC3(-/-) mice leads to decreased muscle size in the adult. Dev. Biol. 232 (2001), 115–126.
73. Keilhack, H., David, F.S., McGregor, M., Cantley, L.C., Neel, B.G., Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes. J. Biol. Chem. 280 (2005), 30984–30993.
74. Keren, B., Hadchouel, A., Saba, S., Sznajer, Y., Bonneau, D., Leheup, B., Boute, O., Gaillard, D., Lacombe, D., Layet, V., Marlin, S., Mortier, G., et al. PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience. J. Med. Genet., 41, 2004, e117.
75. Kirby, M.L., Waldo, K.L., Role of neural crest in congenital heart disease. Circulation 82 (1990), 332–340.
76. Kirby, M.L., Gale, T.F., Stewart, D.E., Neural crest cells contribute to normal aorticopulmonary septation. Science 220 (1983), 1059–1061.
77. Kitamura, T., Nakae, J., Kitamura, Y., Kido, Y., Biggs, W.H. 3rd, Wright, C.V., White, M.F., Arden, K.C., Accili, D., The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J. Clin. Invest. 110 (2002), 1839–1847.
78. Kontaridis, M.I., Eminaga, S., Fornaro, M., Zito, C.I., Sordella, R., Settleman, J., Bennett, A.M., SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway. Mol. Cell. Biol. 24 (2004), 5340–5352.
79. Kontaridis, M.I., Swanson, K.D., David, F.S., Barford, D., Neel, B.G., PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects. J. Biol. Chem. 281 (2006), 6785–6792.
80. Kontaridis, M.I., Yang, W., Bence, K.K., Cullen, D., Wang, B., Bodyak, N., Ke, Q., Hinek, A., Kang, P.M., Liao, R., Neel, B.G., Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways. Circulation 117 (2008), 1423–1435.
81. Krajewska, M., Banares, S., Zhang, E.E., Huang, X., Scadeng, M., Jhala, U.S., Feng, G.S., Krajewski, S., Development of diabesity in mice with neuronal deletion of Shp2 tyrosine phosphatase. Am. J. Pathol. 172 (2008), 1312–1324.
82. Krenz, M., Gulick, J., Osinska, H.E., Colbert, M.C., Molkentin, J.D., Robbins, J., Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome. Proc. Natl. Acad. Sci. USA 105 (2008), 18930–18935.
83. Lawrence, M., Shao, C., Duan, L., McGlynn, K., Cobb, M.H., The protein kinases ERK1/2 and their roles in pancreatic beta cells. Acta Physiol. (Oxf.) 192 (2008), 11–17.
84. Le Douarin, N.M., Creuzet, S., Couly, G., Dupin, E., Neural crest cell plasticity and its limits. Development 131 (2004), 4637–4650.
85. Lemke, G., Neuregulin-1 and myelination. Sci. STKE, 2006, 2006, pe11.
86. Lillien, L., Progenitor cells: what do they know and when do they know it?. Curr. Biol. 8 (1998), R872–R874.
87. Liu, X., Robinson, G.W., Wagner, K.U., Garrett, L., Wynshaw-Boris, A., Hennighausen, L., Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11 (1997), 179–186.
88. Loh, M.L., Reynolds, M.G., Vattikuti, S., Gerbing, R.B., Alonzo, T.A., Carlson, E., Cheng, J.W., Lee, C.M., Lange, B.J., Meshinchi, S., PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group. Leukemia 18 (2004), 1831–1834.
89. Loh, M.L., Vattikuti, S., Schubbert, S., Reynolds, M.G., Carlson, E., Lieuw, K.H., Cheng, J.W., Lee, C.M., Stokoe, D., Bonifas, J.M., Curtiss, N.P., Gotlib, J., et al. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103 (2004), 2325–2331.
90. Lopez-Miranda, B., Westra, S.J., Yazdani, S., Boechat, M.I., Noonan syndrome associated with neuroblastoma: a case report. Pediatr. Radiol. 27 (1997), 324–326.
91. Lyons, D.A., Pogoda, H.M., Voas, M.G., Woods, I.G., Diamond, B., Nix, R., Arana, N., Jacobs, J., Talbot, W.S., erbb3 and erbb2 are essential for schwann cell migration and myelination in zebrafish. Curr. Biol. 15 (2005), 513–524.
92. Marino, B., Digilio, M.C., Toscano, A., Giannotti, A., Dallapiccola, B., Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal. J. Pediatr. 135 (1999), 703–706.
93. Maroun, C.R., Naujokas, M.A., Holgado-Madruga, M., Wong, A.J., Park, M., The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol. Cell. Biol. 20 (2000), 8513–8525.
94. Martinelli, S., Carta, C., Flex, E., Binni, F., Cordisco, E.L., Moretti, S., Puxeddu, E., Tonacchera, M., Pinchera, A., McDowell, H.P., Dominici, C., Rosolen, A., et al. Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors. Cancer Genet. Cytogenet. 166 (2006), 124–129.
95. Menard, C., Hein, P., Paquin, A., Savelson, A., Yang, X.M., Lederfein, D., Barnabe-Heider, F., Mir, A.A., Sterneck, E., Peterson, A.C., Johnson, P.F., Vinson, C., et al. An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis. Neuron 36 (2002), 597–610.
96. Meyer, D., Birchmeier, C., Multiple essential functions of neuregulin in development. Nature 378 (1995), 386–390.
97. Michailov, G.V., Sereda, M.W., Brinkmann, B.G., Fischer, T.M., Haug, B., Birchmeier, C., Role, L., Lai, C., Schwab, M.H., Nave, K.A., Axonal neuregulin-1 regulates myelin sheath thickness. Science 304 (2004), 700–703.
98. Milarski, K.L., Saltiel, A.R., Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol. Chem. 269 (1994), 21239–21243.
99. Miller, F.D., Gauthier, A.S., Timing is everything: making neurons versus glia in the developing cortex. Neuron 54 (2007), 357–369.
100. Miyamoto, D., Miyamoto, M., Takahashi, A., Yomogita, Y., Higashi, H., Kondo, S., Hatakeyama, M., Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors. Oncogene 27 (2008), 3508–3515.
101. Mohi, M.G., Williams, I.R., Dearolf, C.R., Chan, G., Kutok, J.L., Cohen, S., Morgan, K., Boulton, C., Shigematsu, H., Keilhack, H., Akashi, K., Gilliland, D.G., et al. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell 7 (2005), 179–191.
102. Molina, T.J., Kishihara, K., Siderovski, D.P., van Ewijk, W., Narendran, A., Timms, E., Wakeham, A., Paige, C.J., Hartmann, K.U., Veillette, A., et al. Profound block in thymocyte development in mice lacking p56lck. Nature 357 (1992), 161–164.
103. Montagner, A., Yart, A., Dance, M., Perret, B., Salles, J.P., Raynal, P., A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation. J. Biol. Chem. 280 (2005), 5350–5360.
104. Morris, J.K., Lin, W., Hauser, C., Marchuk, Y., Getman, D., Lee, K.F., Rescue of the cardiac defect in ErbB2 mutant mice reveals essential roles of ErbB2 in peripheral nervous system development. Neuron 23 (1999), 273–283.
105. Musante, L., Kehl, H.G., Majewski, F., Meinecke, P., Schweiger, S., Gillessen-Kaesbach, G., Wieczorek, D., Hinkel, G.K., Tinschert, S., Hoeltzenbein, M., Ropers, H.H., Kalscheuer, V.M., Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. Eur. J. Hum. Genet. 11 (2003), 201–206.
106. Nakae, J., Biggs, W.H. 3rd, Kitamura, T., Cavenee, W.K., Wright, C.V., Arden, K.C., Accili, D., Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 32 (2002), 245–253.
107. Nakamura, T., Colbert, M., Krenz, M., Molkentin, J.D., Hahn, H.S., Dorn, G.W. 2nd, Robbins, J., Mediating ERK 1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome. J. Clin. Invest. 117 (2007), 2123–2132.
108. Nakamura, T., Gulick, J., Colbert, M.C., Robbins, J., Protein tyrosine phosphatase activity in the neural crest is essential for normal heart and skull development. Proc. Natl. Acad. Sci. USA 106 (2009), 11270–11275.
109. Nakamura, T., Gulick, J., Pratt, R., Robbins, J., Noonan syndrome is associated with enhanced pERK activity, the repression of which can prevent craniofacial malformations. Proc. Natl. Acad. Sci. USA 106 (2009), 15436–15441.
110. Nakashima, K., Yanagisawa, M., Arakawa, H., Kimura, N., Hisatsune, T., Kawabata, M., Miyazono, K., Taga, T., Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 284 (1999), 479–482.
111. Neel, B.G., Gu, H., Pao, L., The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28 (2003), 284–293.
112. Newbern, J., Zhong, J., Wickramasinghe, R.S., Li, X., Wu, Y., Samuels, I., Cherosky, N., Karlo, J.C., O'Loughlin, B., Wikenheiser, J., Gargesha, M., Doughman, Y.Q., et al. Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development. Proc. Natl. Acad. Sci. USA 105 (2008), 17115–17120.
113. Nguyen, T.V., Ke, Y., Zhang, E.E., Feng, G.S., Conditional deletion of Shp2 tyrosine phosphatase in thymocytes suppresses both pre-TCR and TCR signals. J. Immunol. 177 (2006), 5990–5996.
114. Niihori, T., Aoki, Y., Ohashi, H., Kurosawa, K., Kondoh, T., Ishikiriyama, S., Kawame, H., Kamasaki, H., Yamanaka, T., Takada, F., Nishio, K., Sakurai, M., et al. Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia. J. Hum. Genet. 50 (2005), 192–202.
115. Noguchi, T., Matozaki, T., Horita, K., Fujioka, Y., Kasuga, M., Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol. Cell. Biol. 14 (1994), 6674–6682.
116. Noonan, J.A., Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. Am. J. Dis. Child 116 (1968), 373–380.
117. Noonan, J.A., Noonan syndrome and related disorders: alterations in growth and puberty. Rev. Endocr. Metab. Disord. 7 (2006), 251–255.
118. Noonan, J., Ehmke, D., Associated non cardiac malformations in children with congenital heart disease. J. Pediatr. 63 (1963), 468–470.
119. Ogata, T., Yoshida, R., PTPN11 mutations and genotype-phenotype correlations in Noonan and LEOPARD syndromes. Pediatr. Endocrinol. Rev. 2 (2005), 669–674.
120. Oh, E.S., Gu, H., Saxton, T.M., Timms, J.F., Hausdorff, S., Frevert, E.U., Kahn, B.B., Pawson, T., Neel, B.G., Thomas, S.M., Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2. Mol. Cell. Biol. 19 (1999), 3205–3215.
121. Oishi, K., Gaengel, K., Krishnamoorthy, S., Kamiya, K., Kim, I.K., Ying, H., Weber, U., Perkins, L.A., Tartaglia, M., Mlodzik, M., Pick, L., Gelb, B.D., Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations. Hum. Mol. Genet. 15 (2006), 543–553.
122. Oishi, K., Zhang, H., Gault, W.J., Wang, C.J., Tan, C.C., Kim, I.K., Ying, H., Rahman, T., Pica, N., Tartaglia, M., Mlodzik, M., Gelb, B.D., Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development. Hum. Mol. Genet. 18 (2009), 193–201.
123. Opitz, J.M., The Noonan syndrome. Am. J. Med. Genet. 21 (1985), 515–518.
124. O'Reilly, A.M., Pluskey, S., Shoelson, S.E., Neel, B.G., Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps. Mol. Cell. Biol. 20 (2000), 299–311.
125. Pagani, M.R., Oishi, K., Gelb, B.D., Zhong, Y., The phosphatase SHP2 regulates the spacing effect for long-term memory induction. Cell 139 (2009), 186–198.
126. Pandit, B., Sarkozy, A., Pennacchio, L.A., Carta, C., Oishi, K., Martinelli, S., Pogna, E.A., Schackwitz, W., Ustaszewska, A., Landstrom, A., Bos, J.M., Ommen, S.R., et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat. Genet. 39 (2007), 1007–1012.
127. Park, J.K., Williams, B.P., Alberta, J.A., Stiles, C.D., Bipotent cortical progenitor cells process conflicting cues for neurons and glia in a hierarchical manner. J. Neurosci. 19 (1999), 10383–10389.
128. Perkins, L.A., Larsen, I., Perrimon, N., Corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso. Cell 70 (1992), 225–236.
129. Perkins, L.A., Johnson, M.R., Melnick, M.B., Perrimon, N., The nonreceptor protein tyrosine phosphatase corkscrew functions in multiple receptor tyrosine kinase pathways in Drosophila. Dev. Biol. 180 (1996), 63–81.
130. Princen, F., Bard, E., Sheikh, F., Zhang, S.S., Wang, J., Zago, W.M., Wu, D., Trelles, R.D., Bailly-Maitre, B., Kahn, C.R., Chen, Y., Reed, J.C., et al. Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death. Mol. Cell. Biol. 29 (2009), 378–388.
131. Qu, C.K., Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling and cellular response. Biochim. Biophys. Acta 1592 (2002), 297–301.
132. Qu, C.K., Shi, Z.Q., Shen, R., Tsai, F.Y., Orkin, S.H., Feng, G.S., A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development. Mol. Cell. Biol. 17 (1997), 5499–5507.
133. Qu, C.K., Yu, W.M., Azzarelli, B., Cooper, S., Broxmeyer, H.E., Feng, G.S., Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells. Mol. Cell. Biol. 18 (1998), 6075–6082.
134. Qu, C.K., Nguyen, S., Chen, J., Feng, G.S., Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development. Blood 97 (2001), 911–914.
135. Raballo, R., Rhee, J., Lyn-Cook, R., Leckman, J.F., Schwartz, M.L., Vaccarino, F.M., Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex. J. Neurosci. 20 (2000), 5012–5023.
136. Riethmacher, D., Sonnenberg-Riethmacher, E., Brinkmann, V., Yamaai, T., Lewin, G.R., Birchmeier, C., Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 389 (1997), 725–730.
137. Roberts, A.E., Araki, T., Swanson, K.D., Montgomery, K.T., Schiripo, T.A., Joshi, V.A., Li, L., Yassin, Y., Tamburino, A.M., Neel, B.G., Kucherlapati, R.S., Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat. Genet. 39 (2007), 70–74.
138. Rosário, M., Birchmeier, W., How to make tubes: signaling by the Met receptor tyrosine kinase. Trends Cell Biol. 13 (2003), 328–335.
139. Rosário, M., Franke, R., Bednarski, C., Birchmeier, W., The neurite outgrowth multiadaptor RhoGAP, NOMA-GAP, regulates neurite extension through SHP2 and Cdc42. J. Cell Biol. 178 (2007), 503–516.
140. Rossant, J., Stem cells from the Mammalian blastocyst. Stem Cells 19 (2001), 477–482.
141. Rossant, J., Cross, J.C., Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2 (2001), 538–548.
142. Saba-El-Leil, M.K., Vella, F.D., Vernay, B., Voisin, L., Chen, L., Labrecque, N., Ang, S.L., Meloche, S., An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep. 4 (2003), 964–968.
143. Saxton, T.M., Henkemeyer, M., Gasca, S., Shen, R., Rossi, D.J., Shalaby, F., Feng, G.S., Pawson, T., Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16 (1997), 2352–2364.
144. Schaeper, U., Gehring, N.H., Fuchs, K.P., Sachs, M., Kempkes, B., Birchmeier, W., Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J. Cell Biol. 149 (2000), 1419–1432.
145. Schoenwaelder, S.M., Petch, L.A., Williamson, D., Shen, R., Feng, G.S., Burridge, K., The protein tyrosine phosphatase Shp-2 regulates RhoA activity. Curr. Biol. 10 (2000), 1523–1526.
146. Schubbert, S., Lieuw, K., Rowe, S.L., Lee, C.M., Li, X., Loh, M.L., Clapp, D.W., Shannon, K.M., Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood 106 (2005), 311–317.
147. Schubbert, S., Zenker, M., Rowe, S.L., Boll, S., Klein, C., Bollag, G., van der Burgt, I., Musante, L., Kalscheuer, V., Wehner, L.E., Nguyen, H., West, B., et al. Germline KRAS mutations cause Noonan syndrome. Nat. Genet. 38 (2006), 331–336.
148. Shen, Q., Qian, X., Capela, A., Temple, S., Stem cells in the embryonic cerebral cortex: their role in histogenesis and patterning. J. Neurobiol. 36 (1998), 162–174.
149. Shi, Z.Q., Lu, W., Feng, G.S., The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases. J. Biol. Chem. 273 (1998), 4904–4908.
150. Srivastava, D., Making or breaking the heart: from lineage determination to morphogenesis. Cell 126 (2006), 1037–1048.
151. Sun, Y., Nadal-Vicens, M., Misono, S., Lin, M.Z., Zubiaga, A., Hua, X., Fan, G., Greenberg, M.E., Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell 104 (2001), 365–376.
152. + thymocytes. Proc. Natl. Acad. Sci. USA 93 (1996), 4683–4687.
153. Tanaka, S., Kunath, T., Hadjantonakis, A.K., Nagy, A., Rossant, J., Promotion of trophoblast stem cell proliferation by FGF4. Science 282 (1998), 2072–2075.
154. Tang, T.L., Freeman, R.M. Jr., O'Reilly, A.M., Neel, B.G., Sokol, S.Y., The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. Cell 80 (1995), 473–483.
155. Tartaglia, M., Gelb, B.D., Noonan syndrome and related disorders: genetics and pathogenesis. Annu. Rev. Genomics Hum. Genet. 6 (2005), 45–68.
156. Tartaglia, M., Mehler, E.L., Goldberg, R., Zampino, G., Brunner, H.G., Kremer, H., van der Burgt, I., Crosby, A.H., Ion, A., Jeffery, S., Kalidas, K., Patton, M.A., et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29 (2001), 465–468.
157. Tartaglia, M., Kalidas, K., Shaw, A., Song, X., Musat, D.L., van der Burgt, I., Brunner, H.G., Bertola, D.R., Crosby, A., Ion, A., Kucherlapati, R.S., Jeffery, S., et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am. J. Hum. Genet. 70 (2002), 1555–1563.
158. Tartaglia, M., Niemeyer, C.M., Fragale, A., Song, X., Buechner, J., Jung, A., Hahlen, K., Hasle, H., Licht, J.D., Gelb, B.D., Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat. Genet. 34 (2003), 148–150.
159. Tartaglia, M., Martinelli, S., Cazzaniga, G., Cordeddu, V., Iavarone, I., Spinelli, M., Palmi, C., Carta, C., Pession, A., Arico, M., Masera, G., Basso, G., et al. Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. Blood 104 (2004), 307–313.
160. Tartaglia, M., Martinelli, S., Iavarone, I., Cazzaniga, G., Spinelli, M., Giarin, E., Petrangeli, V., Carta, C., Masetti, R., Arico, M., Locatelli, F., Basso, G., et al. Somatic PTPN11 mutations in childhood acute myeloid leukaemia. Br. J. Haematol. 129 (2005), 333–339.
161. Tartaglia, M., Martinelli, S., Stella, L., Bocchinfuso, G., Flex, E., Cordeddu, V., Zampino, G., Burgt, I., Palleschi, A., Petrucci, T.C., Sorcini, M., Schoch, C., et al. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am. J. Hum. Genet. 78 (2006), 279–290.
162. Tartaglia, M., Pennacchio, L.A., Zhao, C., Yadav, K.K., Fodale, V., Sarkozy, A., Pandit, B., Oishi, K., Martinelli, S., Schackwitz, W., Ustaszewska, A., Martin, J., et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat. Genet. 39 (2007), 75–79.
163. Taveggia, C., Zanazzi, G., Petrylak, A., Yano, H., Rosenbluth, J., Einheber, S., Xu, X., Esper, R.M., Loeb, J.A., Shrager, P., Chao, M.V., Falls, D.L., et al. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47 (2005), 681–694.
164. Ueki, K., Okada, T., Hu, J., Liew, C.W., Assmann, A., Dahlgren, G.M., Peters, J.L., Shackman, J.G., Zhang, M., Artner, I., Satin, L.S., Stein, R., et al. Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes. Nat. Genet. 38 (2006), 583–588.
165. Uhlen, P., Burch, P.M., Zito, C.I., Estrada, M., Ehrlich, B.E., Bennett, A.M., Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling. Proc. Natl. Acad. Sci. USA 103 (2006), 2160–2165.
166. Vogel, W., Lammers, R., Huang, J., Ullrich, A., Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science 259 (1993), 1611–1614.
167. Watson, C.J., Khaled, W.T., Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development 135 (2008), 995–1003.
168. Williams, B.P., Park, J.K., Alberta, J.A., Muhlebach, S.G., Hwang, G.Y., Roberts, T.M., Stiles, C.D., A PDGF-regulated immediate early gene response initiates neuronal differentiation in ventricular zone progenitor cells. Neuron 18 (1997), 553–562.
169. Woldeyesus, M.T., Britsch, S., Riethmacher, D., Xu, L., Sonnenberg-Riethmacher, E., Abou-Rebyeh, F., Harvey, R., Caroni, P., Birchmeier, C., Peripheral nervous system defects in erbB2 mutants following genetic rescue of heart development. Genes Dev. 13 (1999), 2538–2548.
170. Wu, T.R., Hong, Y.K., Wang, X.D., Ling, M.Y., Dragoi, A.M., Chung, A.S., Campbell, A.G., Han, Z.Y., Feng, G.S., Chin, Y.E., SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei. J. Biol. Chem. 277 (2002), 47572–47580.
171. Wu, D., Pang, Y., Ke, Y., Yu, J., He, Z., Tautz, L., Mustelin, T., Ding, S., Huang, Z., Feng, G.S., A conserved mechanism for control of human and mouse embryonic stem cell pluripotency and differentiation by shp2 tyrosine phosphatase. PLoS ONE, 4, 2009, e4914.
172. Wuestefeld, T., Klein, C., Streetz, K.L., Betz, U., Lauber, J., Buer, J., Manns, M.P., Muller, W., Trautwein, C., Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J. Biol. Chem. 278 (2003), 11281–11288.
173. Yamamoto, S., Yoshino, I., Shimazaki, T., Murohashi, M., Hevner, R.F., Lax, I., Okano, H., Shibuya, M., Schlessinger, J., Gotoh, N., Essential role of Shp2-binding sites on FRS2alpha for corticogenesis and for FGF2-dependent proliferation of neural progenitor cells. Proc. Natl. Acad. Sci. USA 102 (2005), 15983–15988.
174. Yamamoto, T., Isomura, M., Xu, Y., Liang, J., Yagasaki, H., Kamachi, Y., Kudo, K., Kiyoi, H., Naoe, T., Kojma, S., PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia. Leuk. Res. 30 (2006), 1085–1089.
175. Yang, W., Klaman, L.D., Chen, B., Araki, T., Harada, H., Thomas, S.M., George, E.L., Neel, B.G., An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev. Cell 10 (2006), 317–327.
176. Yang, Z., Li, Y., Yin, F., Chan, R.J., Activating PTPN11 mutants promote hematopoietic progenitor cell-cycle progression and survival. Exp. Hematol. 36 (2008), 1285–1296.
177. Yoshida, R., Hasegawa, T., Hasegawa, Y., Nagai, T., Kinoshita, E., Tanaka, Y., Kanegane, H., Ohyama, K., Onishi, T., Hanew, K., Okuyama, T., Horikawa, R., et al. Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome. J. Clin. Endocrinol. Metab. 89 (2004), 3359–3364.
178. You, M., Flick, L.M., Yu, D., Feng, G.S., Modulation of the nuclear factor kappa B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor. J. Exp. Med. 193 (2001), 101–110.
179. Yu, D.H., Qu, C.K., Henegariu, O., Lu, X., Feng, G.S., Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J. Biol. Chem. 273 (1998), 21125–21131.
180. Yu, W.M., Daino, H., Chen, J., Bunting, K.D., Qu, C.K., Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 signaling. J. Biol. Chem. 281 (2006), 5426–5434.
181. Zenker, M., Buheitel, G., Rauch, R., Koenig, R., Bosse, K., Kress, W., Tietze, H.U., Doerr, H.G., Hofbeck, M., Singer, H., Reis, A., Rauch, A., Genotype-phenotype correlations in Noonan syndrome. J. Pediatr. 144 (2004), 368–374.
182. Zhang, S.Q., Tsiaras, W.G., Araki, T., Wen, G., Minichiello, L., Klein, R., Neel, B.G., Receptor-specific regulation of phosphatidylinositol 3'-kinase activation by the protein tyrosine phosphatase Shp2. Mol. Cell. Biol. 22 (2002), 4062–4072.
183. Zhang, E.E., Chapeau, E., Hagihara, K., Feng, G.S., Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc. Natl. Acad. Sci. USA 101 (2004), 16064–16069.
184. Zhang, S.S., Hao, E., Yu, J., Liu, W., Wang, J., Levine, F., Feng, G.S., Coordinated regulation by Shp2 tyrosine phosphatase of signaling events controlling insulin biosynthesis in pancreatic beta-cells. Proc. Natl. Acad. Sci. USA 106 (2009), 7531–7536.
185. Zhang, W., Chan, R.J., Chen, H., Yang, Z., He, Y., Zhang, X., Luo, Y., Yin, F., Moh, A., Miller, L.C., Payne, R.M., Zhang, Z.Y., et al. Negative regulation of Stat3 by activating PTPN11 mutants contributes to the pathogenesis of Noonan syndrome and juvenile myelomonocytic leukemia. J. Biol. Chem. 284 (2009), 22353–22363.